Trials / Completed
CompletedNCT04511000
Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg
A Randomized, Open-label, Parallel, Multi-Center Phase IV Study to Compare of the Efficacy and Safety of Lipilou 20 mg and Lipilou 10 mg in High-risk Patients With Hypercholesterolemia(PEARL Study)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to compare the mean percent change of LDL-C between Lipilou® 10mg and 20mg group after 12 weeks of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lipilou®(generic atorvastatin drug) 20 mg | Patients assigned to experimental group are treated with Lipilou® 20 mg |
| DRUG | Lipilou®(generic atorvastatin drug) 10 mg | Patients assigned to comparator group are treated with Lipilou® 10 mg |
Timeline
- Start date
- 2017-10-11
- Primary completion
- 2019-05-20
- Completion
- 2019-05-20
- First posted
- 2020-08-12
- Last updated
- 2020-08-12
Locations
10 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04511000. Inclusion in this directory is not an endorsement.